Kbc Group Nv Johnson & Johnson Transaction History

Kbc Group Nv

$33.1 Billion
Q2 2024

A detailed history of Kbc Group Nv transactions in Johnson & Johnson stock. As of the latest transaction made, Kbc Group Nv holds 1,281,683 shares of JNJ stock, worth $211 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

1,281,683

Previous 925,167 38.54%

Holding current value

$211 Million

Previous $146 Million 28.0%

% of portfolio

0.57%

Previous 0.46%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$144.38 - $157.78 $51.5 Million - $56.3 Million	356,516 Added 38.54%	1,281,683 $187 Million
Q1 2024 May 08, 2024	SELL	$155.22 - $162.74 $135 Million - $142 Million	-870,086 Reduced 48.47%	925,167 $146 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $21.8 Million - $23.8 Million	-150,021 Reduced 7.71%	1,795,253 $281 Million
Q3 2023 Feb 15, 2024	BUY	$155.75 - $174.48 $4.31 Million - $4.83 Million	27,672 Added 1.41%	1,986,179 $309 Million
Q2 2023 Feb 15, 2024	BUY	$154.35 - $166.11 $121 Million - $130 Million	785,004 Added 66.89%	1,958,507 $324 Million
Q2 2023 Jul 28, 2023	BUY	$154.35 - $166.11 $71 Million - $76.4 Million	459,971 Added 30.97%	1,945,274 $322 Million
Q1 2023 Feb 14, 2024	SELL	$151.05 - $180.26 $24.9 Million - $29.8 Million	-165,151 Reduced 9.95%	1,494,300 $232 Million
Q1 2023 May 04, 2023	BUY	$151.05 - $180.26 $47.7 Million - $56.9 Million	315,782 Added 27.0%	1,485,303 $230 Million
Q4 2022 Feb 14, 2024	BUY	$160.2 - $179.79 $74.4 Million - $83.5 Million	464,495 Added 38.87%	1,659,451 $293 Million
Q3 2022 Feb 15, 2024	SELL	$161.33 - $179.52 $100 Million - $112 Million	-621,750 Reduced 34.63%	1,173,503 $192 Million
Q3 2022 Nov 08, 2022	SELL	$161.33 - $179.52 $3.33 Million - $3.71 Million	-20,658 Reduced 1.74%	1,169,521 $191 Million
Q2 2022 Feb 14, 2024	SELL	$168.19 - $186.01 $15 Million - $16.6 Million	-89,185 Reduced 6.95%	1,194,956 $212 Million
Q2 2022 Jul 26, 2022	SELL	$168.19 - $186.01 $15.8 Million - $17.5 Million	-93,962 Reduced 7.32%	1,190,179 $211 Million
Q1 2022 Feb 14, 2024	SELL	$158.14 - $179.59 $38.2 Million - $43.4 Million	-241,425 Reduced 15.83%	1,284,141 $228 Million
Q1 2022 May 06, 2022	SELL	$158.14 - $179.59 $38.2 Million - $43.4 Million	-241,425 Reduced 15.83%	1,284,141 $228 Million
Q4 2021 Feb 14, 2024	SELL	$155.93 - $173.01 $42.1 Million - $46.7 Million	-269,687 Reduced 15.02%	1,525,566 $261 Million
Q4 2021 Feb 03, 2022	BUY	$155.93 - $173.01 $31.9 Million - $35.4 Million	204,679 Added 15.5%	1,525,566 $261 Million
Q3 2021 Nov 10, 2021	BUY	$161.5 - $179.47 $44.6 Million - $49.6 Million	276,379 Added 26.46%	1,320,887 $213 Million
Q2 2021 Aug 11, 2021	BUY	$159.48 - $171.07 $4.43 Million - $4.75 Million	27,765 Added 2.73%	1,044,508 $172 Million
Q1 2021 Apr 26, 2021	SELL	$153.07 - $170.48 $11.6 Million - $12.9 Million	-75,815 Reduced 6.94%	1,016,743 $167 Million
Q4 2020 Feb 10, 2021	BUY	$137.11 - $157.38 $36.7 Million - $42.1 Million	267,756 Added 32.46%	1,092,558 $172 Million
Q3 2020 Oct 28, 2020	SELL	$140.38 - $153.83 $21.9 Million - $23.9 Million	-155,655 Reduced 15.88%	824,802 $123 Million
Q2 2020 Aug 10, 2020	BUY	$128.81 - $155.51 $37.7 Million - $45.5 Million	292,813 Added 42.58%	980,457 $138 Million
Q1 2020 May 04, 2020	SELL	$111.14 - $153.99 $17.5 Million - $24.2 Million	-157,067 Reduced 18.59%	687,644 $90.2 Million
Q4 2019 Feb 11, 2020	SELL	$127.5 - $146.44 $18.2 Million - $20.9 Million	-142,698 Reduced 14.45%	844,711 $123 Million
Q3 2019 Nov 07, 2019	BUY	$126.95 - $142.14 $125 Million - $140 Million	985,109 Added 42830.83%	987,409 $128 Million
Q2 2019 Dec 03, 2019	SELL	$131.15 - $144.24 $121 Million - $133 Million	-924,937 Reduced 99.75%	2,300 $320,000
Q2 2019 Jul 30, 2019	BUY	$131.15 - $144.24 $7.69 Million - $8.46 Million	58,625 Added 6.75%	927,237 $0
Q1 2019 May 10, 2019	BUY	$125.72 - $139.79 $1.41 Million - $1.56 Million	11,177 Added 1.3%	868,612 $0
Q4 2018 Jan 31, 2019	BUY	$122.84 - $147.84 $9.28 Million - $11.2 Million	75,536 Added 9.66%	857,435 $111 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $171,184 - $201,175	1,408 Added 0.18%	781,899 $0
Q2 2018 Aug 03, 2018	SELL	$119.4 - $131.76 $24 Million - $26.4 Million	-200,683 Reduced 20.45%	780,491 $0
Q1 2018 May 09, 2018	SELL	$125.1 - $148.14 $8.77 Million - $10.4 Million	-70,115 Reduced 6.67%	981,174 $0
Q4 2017 Feb 07, 2018	SELL	$131.22 - $143.62 $30.7 Million - $33.6 Million	-233,935 Reduced 18.2%	1,051,289 $0
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $166 Million - $174 Million	1,285,224	1,285,224 $0

Others Institutions Holding JNJ

# of Institutions

4,157

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $430B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account